Mandatory disclosure of pharmaceutical industry-funded events for health professionals.
Jane Robertson, Ray Moynihan, Emily Walkom and 2 more
PLoS Medicine · 2009
doi:10.1371/journal.pmed.1000128 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
David Henry and colleagues examine compliance with new disclosure requirements of Medicines Australia, the pharmaceutical industry representative body, and argue that they fall short and instead more comprehensive reporting standards are needed.
Abstract licence: CC BY
References14
- 8.
13 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.